- Home
- WGS vs GENI Comparison
WGS vs GENI Comparison
Compare WGS & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGS
- GENI
- Stock Information
- Founded
- WGS 2017
- GENI 2016
- Country
- WGS United States
- GENI United Kingdom
- Employees
- WGS N/A
- GENI N/A
- Industry
- WGS Retail: Computer Software & Peripheral Equipment
- GENI Services-Misc. Amusement & Recreation
- Sector
- WGS Technology
- GENI Consumer Discretionary
- Exchange
- WGS Nasdaq
- GENI Nasdaq
- Market Cap
- WGS 1.5B
- GENI 1.6B
- IPO Year
- WGS N/A
- GENI N/A
- Fundamental
- Price
- WGS $68.43
- GENI $9.11
- Analyst Decision
- WGS Strong Buy
- GENI Strong Buy
- Analyst Count
- WGS 5
- GENI 9
- Target Price
- WGS $67.00
- GENI $10.72
- AVG Volume (30 Days)
- WGS 753.8K
- GENI 3.0M
- Earning Date
- WGS 10-29-2024
- GENI 11-12-2024
- Dividend Yield
- WGS N/A
- GENI N/A
- EPS Growth
- WGS N/A
- GENI N/A
- EPS
- WGS N/A
- GENI N/A
- Revenue
- WGS $267,228,000.00
- GENI $462,535,000.00
- Revenue This Year
- WGS $43.70
- GENI $25.95
- Revenue Next Year
- WGS $16.78
- GENI $14.47
- P/E Ratio
- WGS N/A
- GENI N/A
- Revenue Growth
- WGS 29.41
- GENI 18.25
- 52 Week Low
- WGS $1.29
- GENI $4.91
- 52 Week High
- WGS $89.11
- GENI $10.15
- Technical
- Relative Strength Index (RSI)
- WGS 51.05
- GENI 68.98
- Support Level
- WGS $71.45
- GENI $6.72
- Resistance Level
- WGS $82.18
- GENI $10.15
- Average True Range (ATR)
- WGS 7.58
- GENI 0.41
- MACD
- WGS -1.36
- GENI 0.27
- Stochastic Oscillator
- WGS 17.21
- GENI 69.53
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.